Clinical trial
The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in…
NCT00121550 · Copenhagen Trial Unit, Center for Clinical Intervention Research, Other · Completed
Key facts
| NCT number | NCT00121550 |
|---|---|
| Title | The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease |
| Official title | The Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease - a Randomized, Placebo Controlled, Double Blinded, Multicentre, Clinical Trial |
| Lead sponsor | Copenhagen Trial Unit, Center for Clinical Intervention Research, Other |
| Collaborators | Danish Heart Foundation Copenhagen Hospital Corporation The Danish Medical Research Council The 1991 Pharmacy Foundation Abbott Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Disease, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | clarithromycin |
| Enrollment | 4,372 |
| Start date | Oct 1, 1999 |
| Primary completion | Apr 1, 2000 |
| Completion | Sep 1, 2002 |
| First posted | Jul 21, 2005 |
| Last update posted | Aug 11, 2016 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: